Results 1 to 10 of about 8,460 (160)

APOBECs and Herpesviruses [PDF]

open access: yesViruses, 2021
The apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) family of DNA cytosine deaminases provides a broad and overlapping defense against viral infections.
Adam Z. Cheng   +8 more
doaj   +3 more sources

Machine learning-driven classification and prognostic prediction of kidney renal clear cell carcinoma using APOBEC family expression signatures [PDF]

open access: yesScientific Reports
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC) cytidine deaminases are a highly evolutionarily conserved protein family. Their members are closely associated with DNA damage repair and involved in the genesis and progression of
Zhen Ren   +15 more
doaj   +2 more sources

APOBEC in breast cancer: a dual player in tumor evolution and therapeutic response [PDF]

open access: yesFrontiers in Molecular Biosciences
The APOBEC (Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like) family of cytidine deaminases has emerged as pivotal a contributor to genomic instability and adaptive immunity through DNA/RNA editing. Accumulating evidence underscores their
Haiqi Lu   +5 more
doaj   +2 more sources

Comprehensive Insights into APOBEC Mutations in Thyroid Cancer: Prognostic and Therapeutic Discoveries [PDF]

open access: yesBiological Procedures Online
Background The APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) family plays a vital mutagenic role in diverse human malignancies.
Wei Luo   +15 more
doaj   +2 more sources

Characterization of a synthetic infectious cloned DNA of simian foamy virus serotype 1 [PDF]

open access: yesnpj Viruses
A virus stock of a cloned infectious DNA of simian foamy virus serotype 1 (SFV-1) was obtained in M. dunni cells (designated as pSFV-MD). The kinetics of replication were similar to the parent uncloned SFV-MD stock in M.
Sandra M. Fuentes   +4 more
doaj   +2 more sources

Genomic characterization of tumor mutational burden-high breast carcinomas [PDF]

open access: yesnpj Precision Oncology
Tumor mutational burden (TMB) has emerged as a potential surrogate for neoantigen load and an indicator of immune checkpoint (IC)-blockade response; however, its precise significance in breast cancer (BC) is not fully understood. Here, we comprehensively
Theodore Vougiouklakis   +10 more
doaj   +2 more sources

APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma

open access: yesViruses, 2021
APOBEC is a mutagenic source in human papillomavirus (HPV)-mediated malignancies, including HPV+ oropharyngeal squamous cell carcinoma (HPV + OPSCC), and in HPV genomes.
Daniel L. Faden   +13 more
doaj   +1 more source

SARS-CoV-2 variants: origin, drivers and prevention measures

open access: yesShanghai yufang yixue, 2022
COVID-19 has emerged around the world since December 2019 and rapidly evolves as a major global public health challenge. SARS-CoV-2 is a positive single-stranded RNA virus with a relatively high natural mutation rate. The emergence of SARS-CoV-2 variants
SHEN Jiaying   +2 more
doaj   +1 more source

Constructing an APOBEC-related gene signature with predictive value in the overall survival and therapeutic sensitivity in lung adenocarcinoma

open access: yesHeliyon, 2023
Background: APOBEC family play an important role in cancer mutagenesis and tumor development. The role of APOBEC family in lung adenocarcinoma (LUAD) has not been studied comprehensively.
Yu Luo   +6 more
doaj   +1 more source

APOBEC-1 deletion enhances cisplatin-induced acute kidney injury

open access: yesScientific Reports, 2023
Cisplatin (CP) induces acute kidney injury (AKI) whereby proximal tubules undergo regulated necrosis. Repair is almost complete after a single dose. We now demonstrate a role for Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 (Apobec-1 ...
Xiaojia Guo   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy